תבנית:תרופה/סימולקט 20 מ"ג - Simulect 20 mg: הבדלים בין גרסאות

L04AA
Selective immunosuppressants

• Basiliximab 20 MG/VIAL ‏L04AA09
• Elective immunosuppressive agents L04AA ‏L04AA09
• Selective immunosuppressive agents L04AA ‏L04AA09
• 7290001180310 לא ‏L04AA09
• Beethovenstrasse 6, 8010 GRAZ, AUSTRIA steriliey testing of the solvent ‏L04AA09
• Lichtstrasse 35, CH-4056 BASEL, SWITZERLAND bulk of active ingredient, QC testing of active ingredient, (except Assay of Phosphate and Chloride, assay of Sodium and Potassium) , drug product QC site - Activity/Binding assay ‏L04AA09
• Centre biotechnologie, 8 RUE DE I'INDUSTRIE, 68330 HUNINGUE, FRANCE bulk of active ingredient, QC testing of active ingredient, (except determination of Host cell protein, activity/binding assay, assay of Phosphate and Chloride, assay of Sodium and Potassium) ‏L04AA09
• Schaffhauserstrasse ch-4332,stein,switzerland secondary packing of solvent , technical release of solvent , Technical Release of powder , manufacture of bulk drug product, primary and secondary packaging, quality control - all tests except Activity/Binding assay ( Identity/assay) ‏L04AA09
• Romerpark 2, CH-4303, KAISERAUGST, SWITZERLAND QC testing of active ingredient (Assay of Phosphate and Chloride & Assay of sodium and Phosphate) ‏L04AA09
• St. peterstrasse 25, 4020 LINZ, AUSTRIA manufacturing and primary packaging and QC (except sterility testing) of the solvent ‏L04AA09
• Basiliximab 20 MG/VIAL ‏L04AA09

• עלון לרופא
• עלון לרופא